Paid Clinical Trials in Irving, TX

As of September 2026, 115 paid clinical trials are recruiting in Irving, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

110 clinical trials

Get a weekly email when new trials open in Irving, TX.

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

for Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

Sites in Irving, San Antonio +4 more locations

Sponsor: DualityBio Inc.

Sex: All·Age: 18 - 70·Accepts healthy volunteers

Code: NCT06625671·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study of HS-20110 in Participants With Advanced Solid Tumors

for Solid Tumors

Sites in Irving, Houston +5 more locations

Sponsor: Hansoh BioMedical R&D Company

Sex: All·Age: 18+

Code: NCT06892379·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

for Locally Advanced Unresectable or Metastatic Solid Tumors

Sites in Irving, Austin & San Antonio

Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All·Age: 18+

Code: NCT05458219·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Irving, Houston +5 more locations

Sponsor: Tagworks Pharmaceuticals BV

Sex: All·Age: 18+

Code: NCT06959706·Phase 1·Recruiting·Listed May 2025

Apply to this trial

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Irving, Austin +5 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06804824·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

for Metastatic Solid Tumors

Sites in Irving, Houston +3 more locations

Sponsor: Erasca, Inc.

Sex: All·Age: 18 - 99

Code: NCT07021898·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for Prostate Cancer Castration-resistant Prostate Cancer

Sites in Irving, San Antonio +5 more locations

Sponsor: MBrace Therapeutics

Sex: All·Age: 18+

Code: NCT07145255·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

for Solid Tumors

Sites in Irving, Houston +4 more locations

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Sex: All·Age: 18 - 75

Code: NCT06963281·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors

for Solid Tumors, Adult

Sites in Irving & San Antonio

Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Sex: All·Age: 18+

Code: NCT06504368·Phase 1·Recruiting·Listed Jul 2024

Apply to this trial

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

for Cancer

Sites in Irving, Austin +2 more locations

Sponsor: OncoResponse, Inc.

Sex: All·Age: 18+

Code: NCT06090266·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Registry Study for Radiation Therapy Outcomes

for Neoplasms

Sites in Irving +28 more locations

Sponsor: Proton Collaborative Group

Sex: All·Age: All ages

Code: NCT01255748·Recruiting·Listed Dec 2010

Apply to this trial

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

for Pediatric Patients Treated With Radiation Therapy

Sites in Irving, Houston +21 more locations

Sponsor: Massachusetts General Hospital

Sex: All·Age: Up to 21

Code: NCT01696721·Recruiting·Listed Oct 2012

Apply to this trial

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

for Failed or Difficult Intubation, Sequela

Sites in Irving, Dallas +49 more locations

Sponsor: Children's Hospital of Philadelphia

Sex: All·Age: All ages

Code: NCT02493478·Recruiting·Listed Jul 2015

Apply to this trial

Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution

for Congenital Myasthenic Syndrome

Sites in Irving +1 more location

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All·Age: 18+

Code: NCT07226726·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up

for Cancer

Sites in Irving +2 more locations

Sponsor: Center for Biomedical Research, LLC

Sex: All·Age: All ages

Code: NCT02070328·Recruiting·Listed Feb 2014

Apply to this trial

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

for Weight Management

Sites in Irving, Dallas +53 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07667803·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

for Type 2 Diabetes Mellitus

Drug: Dapagliflozin

Sites in Irving +23 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07662044·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome

for Rett Syndrome

Sites in Irving, Houston +4 more locations

Sponsor: UCB BIOSCIENCES, Inc.

Sex: All·Age: 5 - 35

Code: NCT07503444·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

for Treatment-resistant Depression (TRD)

Sites in Irving, Dallas +36 more locations

Sponsor: Alto Neuroscience

Sex: All·Age: 18 - 75

Code: NCT07553637·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Study of DS5361b in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Irving, San Antonio +3 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT07182591·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for Non-alcoholic Fatty Liver Disease

Sites in Irving, Dallas +74 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 75

Code: NCT07221227·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for Non-squamous Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Irving, Fort Worth +60 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06627647·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for Graves' Disease

Drug: IMVT-1402

Sites in Irving, Dallas +31 more locations

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 75

Code: NCT07018323·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

Sites in Irving, Euless +308 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

for Breast Cancer, Early Breast Cancer

Drug: Camizestrant

Sites in Irving +3 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05774951·Phase 3·Recruiting·Listed Mar 2023

Apply to this trial

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for Solid Tumor

Sites in Irving, Austin +14 more locations

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT06874335·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

Randomized Withdrawal Study in Patients With Schizophrenia

for Schizophrenia

Sites in Irving, Richardson +20 more locations

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT06961968·Phase 3·Recruiting·Listed May 2025

Apply to this trial